Literature DB >> 1097509

Antagonism of B lymphocyte mitogenesis by anti-immunoglobulin antibody.

J W Schrader.   

Abstract

Anti-mouse-immunoglobulin-antibodies (AMIg) were shown to suppress mitogenesis in B lymphocytes that were cultured with lipopolysaccharide, (LPS), or polymerized-flagellin, (POL). Preincubation of spleen cells with AMIg plus LPS has a greater suppressive effect on a subsequent mitogenic response to LPS than did preincubation with AMIg alone. Preincubation with LPS alone had, if anything, a slight enhancing effect. These experiments suggested that AMIg did not suppress mitogenesis by interference with the initial binding of the mitogen, but rather exerted a separated negative effect that occurred subsequent to, or in the process of, B cell-stimulation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1097509

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Control of proliferation and differentiation in B lymphocytes by anti-Ig antibodies and a serum-derived cofactor.

Authors:  C L Sidman; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

2.  Mechanisms of clonal abortion tolerogenesis. II. Clonal behaviour of immature B cells following exposure to anti-mu chain antibody.

Authors:  G J Nossal; B L Pike; F L Battye
Journal:  Immunology       Date:  1979-05       Impact factor: 7.397

3.  Intracellular lymphocyte activation and carrier-mediated transport of C8-substituted guanine ribonucleosides.

Authors:  M G Goodman; W O Weigle
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

4.  Characteristics of human B cells responsive to the T-independent mitogen Branhamella catarrhalis.

Authors:  J E Calvert; A Calogeras
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

5.  Control of B-lymphocyte function. I. Inactivation of mitogenesis by interactions with surface immunoglobulin and Fc-receptor molecules.

Authors:  C L Sidman; E R Unanue
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.